α‐fetoprotein: Reevaluation in hepatology

Hepatology

Volumn 12, Issue 6, 1990, Pages 1420-1432

  Taketa, Kazuhisa ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

HEPATITIS; LIVER DISEASE; LIVER FUNCTION; LIVER RESECTION; PRIORITY JOURNAL; REVIEW;

ALPHA-FETOPROTEINS; ANIMAL; HUMAN; LIVER DISEASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0025696558     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840120625     Document Type: Article

References (174)

1. Demonstration of new protein fraction in serum from the human fetus
2. Identification of a new normal embryonic haemoglobin
3. Production of embryonal α‐globulin by transplantable mouse hepatomas
4. Presence of embryospecific α‐globulin in the serum of patients with primary hepatocellular carcinoma
5. Embryonal serum α‐globulin in cancer patients: diagnostic value
6. Occurrence of fetoprotein in patients with neoplasms and nonneoplastic diseases
7. The past and the future for cancer testing by alpha‐fetoprotein: a review
8. 1 fetoglobulin in the diagnosis of human hepatoma
9. Studies of carcino‐fetal proteins. III. Development of a radioimmunoassay for alpha‐fetoprotein: demonstration of alpha‐fetoprotein in serum of healthy human adults
10. Radioimmunoassay of α‐fetoprotein in hepatoma, other liver diseases, and pregnancy
11. Serum alpha‐fetoprotein: diagnostic significance in liver disease
12. Human alpha‐1 fetoprotein
13. Alpha‐fetoprotein in liver cirrhosis. I. Prognostic and diagnostic significance of the transient rise of serum alpha‐fetoprotein
14. Cell position and cell interactions in expression of fetal phenotype of hepatocyte
15. Interaction of a hepatoma‐specific nuclear factor with transcription‐regulatory sequences of the human α‐fetoprotein and albumin genes
16. Transcriptional regulation of α‐fetoprotein expression by dexamethasone in human hepatoma cells
17. Molecular mechanisms of up‐ and down‐regulation of the human α‐fetoprotein gene [Abstract]
18. Elevations in serum alphafetoprotein levels in patients with chronic hepatitis B
19. Prognostic significance of alpha‐fetoprotein in chronic viral hepatitis: results of a long‐term follow‐up study [Abstract]
20. Clinical significance of serum alphafetoprotein in patients with liver cirrhosis
21. Hepatocellular cancer
22. Microheterogeneity of alpha‐fetoprotein in patient serum as demonstrated by lectin affino‐electrophoresis
23. Lectin affinities of alpha‐fetoprotein in liver cirrhosis, hepatocellular carcinoma and metastatic liver tumor
24. Model systems of AFP and CEA expression
25. Alpha‐fetoprotein and its relevance to human disease
26. Diagnostic applications of alpha‐fetoprotein: government regulations prevent full application of a clinically useful test
27. Alpha‐fetoprotein: 25 years of study
28. International workshop on alpha‐fetoprotein: new trends and perspectives
29. Primary structures of human α‐fetoprotein and its mRNA
30. Structure, polymorphism and novel repeated DNA elements revealed by a complete structure of the human α‐fetoprotein gene
31. Comparative study on the binding of estrogens by human and rat serum proteins in development
32. Human group‐specific component (Gc) is a member of the albumin family
33. Serum vitamin D—binding protein is a third member of the albumin and alpha fetoprotein gene family
34. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium
35. Vitamin D—binding protein synthesized by a human hepatocellular carcinoma cell line
36. The presence of fatty acids in human α‐fetoprotein
37. Alpha‐fetoprotein receptors in a human breast cancer cell line
38. 3H‐arachidonic acid bound to AFP by autoradiography in rat rhabdomyosarcoma cells
39. Embryonal carcinoma and α‐fetoprotein with special reference to hepatoblastoma
40. Suppression of the immune response by α‐fetoprotein
41. Lipid interactions with human alpha‐fetoprotein (AFP): a study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation
42. Radioimmunoassay of α‐fetoprotein. I. Technique and serum levels in the normal adult
43. α‐Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis
44. Monitoring very low levels of AFP in the early detection of tumor recurrency
45. Biological variation of alpha‐fetoprotein levels in normal adults [Abstract]
46. Development of AFP radioimmunoassay with monoclonal antibodies and its clinical evaluation
47. Evaluation of alpha‐fetoprotein in early infancy
48. Hereditary persistence of alphafetoprotein: a new autosomal dominant trait identified in the antenatal screening programme for spina bifida [Abstract]
49. Hereditary persistence of alphafetoprotein maps to the long arm of chromosome 4 [Abstract]
50. Hereditary persistence of alpha‐fetoprotein
51. Serum α‐fetoprotein levels in patients with cystic fibrosis and their parents and siblings
52. An extremely rare adult case with high alpha‐fetoprotein in serum and with normal liver cells stained partially with alpha‐fetoprotein
53. 1‐fetoprotein in patients with viral hepatitis
54. Serum alphafetoprotein in hepatocellular carcinoma
55. α‐Fetoprotein (AFP) in benign liver disease: evidence that normal liver regeneration does not induce AFP synthesis
56. Relationship of hepatitis B surface antigen to serum α‐fetoprotein in nonmalignant diseases of the liver
57. Marked increase in serum α‐fetoprotein level in cirrhosis: a case report
58. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody‐positive patients
59. Relation of alpha‐fetoprotein in acute hepatitis to severity and prognosis
60. Serum α‐fetoprotein in patients with massive hepatic necrosis
61. α‐Fetoprotein in nonneoplastic hepatic disorders
62. α‐Fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the α‐fetoprotein level
63. Alpha‐fetoprotein and acute viral hepatitis type B
64. Alphafetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma
65. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: a study in 22 patients
66. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
67. Serum α‐fetoprotein in the early stage of human hepatocellular carcinoma
68. Tyrosinémie héréditaire et alpha‐1‐foetoprotéine. I. Intérét clinique de l'alpha‐foeto‐protéine dans la tyrosinémie héréditaire
69. Serum alpha‐fetoprotein levels in patients with ataxia‐telangiectasia
70. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alphafetoprotein levels
71. Primary liver cancer in Japan: sixth report
72. Survey and follow‐up study of primary liver cancer in Japan: report 8
73. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of realtime ultrasonography: a study in 51 patients
74. Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow‐up and treatment
75. Early recognition of hepatocellular carcinoma
76. Biopsy diagnosis of well‐differentiated hepatocellular carcinoma based on new morphologic criteria
77. The significance of alpha‐fetoprotein and other tumor markers in differential immunocytochemistry of primary liver tumors
78. Hepatocellular carcinoma without cirrhosis in Japanese patients
79. 12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma
80. Serum alpha‐fetoprotein positive stomach cancer
81. The use of a radioimmunoassay for alpha‐fetoprotein in the diagnosis of malignancy
82. Serum α‐fetoprotein in patients with neoplasms of the gastrointestinal tract
83. A case of α‐fetoprotein (AFP)‐producing gastric cancer: the review of 114 cases of AFP‐producing gastric cancer in Japan
84. Hepatoid adenocarcinomas of the stomach: an analysis of seven cases
85. Immunocytochemical localization of alphafetoprotein (AFP) and serum albumin (Alb) in ecto‐, meso‐ and endodermal derivative of the developing rat
86. The in vitro production of alpha‐fetoprotein variants by human fetal organs
87. Lectin reactivity of alpha‐fetoprotein in a case of renal cell carcinoma
88. Elevated serum alpha fetoprotein levels in postmenopausal women with primary breast carcinoma
89. Radioimmunoassay of alpha‐fetoprotein in the serum of patients with leukemia and malignant melanoma
90. Carcinoembryonic antigen, alphafetoprotein and alpha and beta subunits of human chorionic gonadotropin in plasma of children with acute leukemia
91. Localization of radioiodinated antibody to α‐fetoprotein in hepatoma transplanted in rats and a case report of α‐fetoprotein antibody treatment of a hepatoma patient
92. Clinical studies on the radioimmunodetection of tumors containing alpha‐fetoprotein
93. The use of a monoclonal antibody against α‐fetoprotein for the radioimmunodetection of hepatocellular carcinoma
94. The effect of anti‐α‐fetoprotein‐adriamycin conjugate on a human hepatoma
95. The use of radioiodinated alpha‐fetoprotein for the scintigraphic detection of mouse mammary carcinomas
96. Alpha‐fetoprotein in ontogenesis and its association with malignant tumors
97. 4 intoxication and partial hepatectomy
98. 1‐fetoprotein production in rats following carbon tetrachloride injury and partial hepatectomy
99. Prompt elevation of rat serum α‐fetoprotein by acute liver injury following a single injection of ethionine
100. 1‐fetoprotein production in hepatic injury
101. 1‐fetoprotein: appearance after galactosamine‐induced liver injury
102. Serum alpha‐fetoprotein: a prognostic indicator of liver‐cell necrosis and regeneration following experimental injury by galactosamine in rats
103. Serum alphafetoprotein in patients following partial hepatectomy
104. Profiles of carbohydrate‐metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers
105. Production of albumin and α‐fetoprotein in primary culture of fetal human liver cells on collagenous substrata in the presence of hydrocortisone
106. Theoretical mechanisms for synthesis of carcinogen‐induced embryonic proteins. I. Alpha‐fetoprotein induction by ethionine
107. α‐Fetoprotein gene methylation and hepatocarcinogenesis in rats fed a choline‐devoid diet
108. Albumin and α‐fetoprotein gene expression in various nonhepatic rat tissues
109. The clonal evolution of tumor cell populations
110. Hormonal control of α‐fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium
111. Detection of alphafetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue
112. Analysis of alphafetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization
113. Human alpha‐fetoprotein: isolation, characterization, and demonstration of microheterogeneity
114. Inhibition of human lymphocyte transformation by human alpha‐fetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism
115. Heterogeneity of human alpha‐fetoprotein as revealed by isoelectric focusing in ureacontaining gels
116. Variants of alphafetoprotein
117. 1‐Fetoprotein: separation of two molecular variants by affinity chromatography with concanavalin A‐agarose
118. Detection of biospecific interaction during the first dimension electrophoresis in crossed immunoelectrophoresis
119. 1‐fetoprotein as revealed by polyacrylamide gel electrophoresis and by crossed immuno‐affinoelectrophoresis with different lectins
120. Lentil‐lectinreactive alpha‐fetoprotein in the differential diagnosis of benign and malignant liver disease
121. Affinity chromatographic separation of alpha‐fetoprotein variants: development of a mini‐column procedure, and application to cancer patients
122. Differential reactivity of α‐fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma
123. Antibody‐affinity blotting, a sensitive technique for the detection of α‐fetoprotein separated by lectin affinity electrophoresis in agarose gels
124. A tetrazolium method for peroxidase staining: application to the antibody‐affinity blotting of α‐fetoprotein separated by lectin affinity electrophoresis
125. Lectin affinity electrophoresis of α‐fetoprotein in cancer diagnosis
126. α‐Fetoprotein antibody‐lectin enzyme immunoassay to characterize sugar chains for the study of liver diseases
127. Carbohydrate differentiation antigens recognized by monoclonal antibodies
128. Monoclonal antibodies with fine specificities distinguishing alpha‐fetoproteins of hepatoma and yolk sac tumor origin
129. Close topographical relationship in alpha foetoprotein (AFP) between a Lens culinaris binding glycan and the epitope recognized by AFP‐reactive monoclonal antibody, 18H4
130. A sensitive blotting system for detection of α‐fetoprotein variants with monoclonal and polyclonal antibodies
131. A lectin‐based monoclonal enzyme immunoassay to distinguish fucosylated and non‐fucosylated α‐fetoprotein molecular variants
132. Allomyrina dichotoma lectin‐nonreactive α‐fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin‐I
133. Differential tumor specificities of asialo‐α‐fetoproteins separated by affinity electrophoresis with E‐PHA and allo A lectins
134. Developmental changes in carbohydrate moiety of human alpha‐fetoprotein
135. Concanavalin‐A‐affinity molecular heterogeneity of human hepatoma AFP and cordserum AFP
136. Alphafetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed‐line affinity immunoelectrophoresis
137. Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries
138. Microheterogeneity forms of alpha‐fetoprotein present in amniotic fluid
139. Lectin‐reactive profiles of alpha‐fetoprotein characterizing hepatocellular carcinoma and related conditions
140. Analysis of lectin affinity immunoelectrophoretic profiles of serum alphafetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlation with molecular structures
141. Serum alphafetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin‐E
142. A primary lung carcinoma producing alpha‐fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin
143. Three‐dimensional crossed immunoelectrophoresis for two‐dimensional lectin affinity electrophoresis of human α‐fetoprotein
144. Further resolution of human α‐fetoprotein by affinity electrophoresis with erythroagglutinating phytohemagglutinin of Phaseolus vulgaris lectin
145. Alphafetoprotein subfractions in amniotic fluid identified by a modification of the method of concanavalin A, lentil lectin or phytohemagglutinin‐E affinity crossed‐line immunoelectrophoresis
146. Datura stramonium agglutinin‐reactive α‐fetoprotein isoforms in hepatocellular carcinoma and other tumors
147. Serum alpha‐fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage
148. Three different types of alpha‐fetoprotein in the diagnosis of malignant solid tumours: use of a sensitive lectin‐affinity immunoelectrophoresis
149. Two‐dimensional lectin affinity electrophoresis of α‐fetoprotein: characterization of erythroagglutinating phytohemagglutinin‐dependent microheterogeneity forms
150. Tissue of origin of elevated alpha‐fetoprotein in ataxia‐telangiectasia
151. AFP carbohydrate heterogeneity as a marker for premalignancy and malignancy
152. Structure of the asparagine‐linked sugar chains of α‐fetoprotein purified from human ascites fluid
153. Sugar chain of α‐fetoprotein produced in human yolk sac tumor
154. Fractionation of glycopeptides by affinity column chromatography on concanavalin A‐sepharose
155. Structural determinants of Phaseolus vulgaris erythroagglutinating lectin for oligosaccharides
156. Fucosylation of serum α‐fetoprotein in patients with primary hepatocellular carcinoma
157. The carbohydrate‐binding specificity of pea and lentil lectins: fucose is an important determinant
158. Carbohydrate binding specificity of immobilized Allomyrina dichotoma lectin II
159. Carbohydrate binding properties of complex‐type oligosaccharides on immobilized Datura stramonium lectin
160. The fucosylation index of alpha‐fetoprotein and its usefulness in early diagnosis of hepatocellular carcinoma
161. Early diagnosis of hepatocellular carcinoma with lectin electrophoresis of serum alpha‐fetoprotein
162. Aldolase A isozyme levels in serum and tissues of patients with liver diseases
163. Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines
164. Immunohistochemical and affinity electrophoretic studies of α‐fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space
165. Retroperitoneal immature teratoma producing alpha‐fetoprotein
166. Serum alpha‐fetoprotein and its lectin reactivity in liver diseases: a review